TMDX (TransMedics Group) Interest Expense: $-17.5 Mil (TTM As of Mar. 2026)

What is TransMedics Group Interest Expense?

TransMedics Group TMDX +1.49% 69 Interest Expense is $-17.5 Mil as of Mar. 2026. GuruFocus rates TMDX with a GF Score™ of 69/100 and a GF Value™ of $167.77 (Possible Value Trap). The stock has 9 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. TransMedics Group's interest expense for the three months ended in Mar. 2026 was $ -7.2 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-17.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. TransMedics Group's Operating Income for the three months ended in Mar. 2026 was $ 13.3 Mil. TransMedics Group's Interest Expense for the three months ended in Mar. 2026 was $ -7.2 Mil. TransMedics Group's Interest Coverage for the quarter that ended in Mar. 2026 was 1.85. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TransMedics Group (NAS:TMDX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TransMedics Group's Interest Expense for the three months ended in Mar. 2026 was $-7.2 Mil. Its Operating Income for the three months ended in Mar. 2026 was $13.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $844.9 Mil.

TransMedics Group's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	13.297	/	-7.17
	=	1.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

TransMedics Group Interest Expense Historical Data

* Premium members only.

The historical data trend for TransMedics Group's Interest Expense can be seen below:

TransMedics Group Interest Expense Chart

TransMedics Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-3.87

-3.73

-10.79

-14.41

-13.78

TransMedics Group Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-3.46	-3.48	-3.49	-3.35	-7.17

69GF Score

TransMedics Group Inc TMDX

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

TransMedics Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.5 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-17.5 Mil mean?

TransMedics Group (TMDX) has a Interest Expense of $-17.5 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on TransMedics Group and its competitors.

Is TransMedics Group's Interest Expense too high?

TransMedics Group's current Interest Expense is $-17.5 Mil. Overall, TransMedics Group has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does TransMedics Group's Interest Expense compare to AXGN and BFLY?

TransMedics Group's Interest Expense of $-17.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on TransMedics Group and its competitors. TransMedics Group's current Interest Expense is $-17.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is TransMedics Group stock overvalued right now?

Based on GuruFocus' analysis, TransMedics Group (TMDX) is currently considered Possible Value Trap. The stock's GF Value™ is $167.77, compared to a current price of $68.86 — trading 59% below its estimated fair value. The current Interest Expense is $-17.5 Mil. TransMedics Group's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For TransMedics Group (TMDX), the current Interest Expense is $-17.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TransMedics Group (TMDX) Overvalued in 2026?

Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued. The current stock price of $68.86 is trading 59% below its estimated GF Value™ of $167.77. GuruFocus considers TransMedics Group to be Possible Value Trap.

Key valuation signals for TMDX:

Interest Expense: $-17.5 Mil
GF Value™: $167.77 vs. price of $68.86 (59% below fair value)
GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the TMDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TransMedics Group Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies AXGN BFLY ESTA NEOG UFPT ALMR NVCR ITGR IART ATEC ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges TMDX:Mexico 1TMDX:Italy TMDX:Germany

Address 200 Minuteman Road, Andover, MA, USA, 01810

Website https://www.transmedics.com

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

69GF Score

Get the complete analysis for TMDX

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$68.86

Price

$167.77

GF Value

View TMDX Analysis

See Interest Expense data for all stocks →